» Articles » PMID: 29691718

Ursodeoxycholic Acid Inhibits Inflammatory Responses and Promotes Functional Recovery After Spinal Cord Injury in Rats

Overview
Journal Mol Neurobiol
Date 2018 Apr 26
PMID 29691718
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to investigate the anti-inflammatory effects by ursodeoxycholic acid (UDCA) in rats with a spinal cord injury (SCI). A moderate mechanical compression injury was imposed on adult Sprague-Dawley (SD) rats. The post-injury locomotor functions were assessed using the Basso, Beattie, and Bresnahan (BBB) locomotor scale and the tissue volume of the injured region was analyzed using hematoxylin and eosin staining. The pro-inflammatory factors were evaluated by immunofluorescence (IF) staining, a quantitative real-time polymerase chain reaction (qRT-PCR), and enzyme-linked immunosorbent assay (ELISA). The phosphorylation of the extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 in mitogen-activated protein kinase (MAPK) signaling pathways related to inflammatory responses were measured by Western blot assays. UDCA improved the BBB scores and promoted the recovery of the spinal cord lesions. UDCA inhibited the expression of glial fibrillary acidic protein (GFAP), tumor necrosis factor-α (TNF-α), ionized calcium-binding adapter molecule 1 (iba1), and inducible nitric oxide synthase (iNOS). UDCA decreased the pro-inflammatory cytokines of TNF-α, interleukin 1-β (IL-1β), and interleukin 6 (IL-6) in the mRNA and protein levels. UDCA increased the anti-inflammatory cytokine interleukin 10 (IL-10) in the mRNA and protein levels. UDCA suppressed the phosphorylation of ERK, JNK, and the p38 signals. UDCA reduces pro-inflammatory responses and promotes functional recovery in SCI in rats. These results suggest that UDCA is a potential therapeutic drug for SCI.

Citing Articles

Nicotinamide Mononucleotide Restores NAD Levels to Alleviate LPS-Induced Inflammation via the TLR4/NF-κB/MAPK Signaling Pathway in Mice Granulosa Cells.

Ahmed M, Riaz U, Lv H, Amjad M, Ahmed S, Ali S Antioxidants (Basel). 2025; 14(1).

PMID: 39857373 PMC: 11762685. DOI: 10.3390/antiox14010039.


Cardioprotective Effects of Ursodeoxycholic Acid in Isoprenaline-Induced Myocardial Injury in Rats.

Mihajlovic D, dukanovic D, Gajic Bojic M, Jovicic S, Mandic-Kovacevic N, Uletilovic S Biomolecules. 2024; 14(10).

PMID: 39456147 PMC: 11506574. DOI: 10.3390/biom14101214.


Every-other-day fasting inhibits pyroptosis while regulating bile acid metabolism and activating TGR5 signaling in spinal cord injury.

Song H, Pang R, Chen Z, Wang L, Hu X, Feng J Front Mol Neurosci. 2024; 17:1466125.

PMID: 39328272 PMC: 11424537. DOI: 10.3389/fnmol.2024.1466125.


Combined analysis of cecal microbiota and metabolomics reveals the intervention mechanism of Dayuan Yin in acute lung injury.

Zhang L, Zhu W, Zhang Z Front Pharmacol. 2024; 15:1436017.

PMID: 39318776 PMC: 11420052. DOI: 10.3389/fphar.2024.1436017.


Causal Relationship Between Gut Microbiota and Chronic Obstructive Pulmonary Disease: A Bidirectional Two-Sample Mendelian Randomization Study.

Li W, Yao C, Han L, Zhou J, Pang R Int J Chron Obstruct Pulmon Dis. 2024; 19:1957-1969.

PMID: 39247666 PMC: 11379542. DOI: 10.2147/COPD.S464917.


References
1.
Sweitzer S, Colburn R, Rutkowski M, DeLeo J . Acute peripheral inflammation induces moderate glial activation and spinal IL-1beta expression that correlates with pain behavior in the rat. Brain Res. 1999; 829(1-2):209-21. DOI: 10.1016/s0006-8993(99)01326-8. View

2.
Cheng Y, Tauschel H, Nilsson A, Duan R . Ursodeoxycholic acid increases the activities of alkaline sphingomyelinase and caspase-3 in the rat colon. Scand J Gastroenterol. 1999; 34(9):915-20. DOI: 10.1080/003655299750025408. View

3.
Bethea J, Nagashima H, Acosta M, Briceno C, Gomez F, Marcillo A . Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma. 1999; 16(10):851-63. DOI: 10.1089/neu.1999.16.851. View

4.
Hayashi M, Ueyama T, Nemoto K, Tamaki T, Senba E . Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury. J Neurotrauma. 2000; 17(3):203-18. DOI: 10.1089/neu.2000.17.203. View

5.
Kim G, Ahmed S, Xu J, Yan P, Xu X, Hsu C . Glucocorticoid receptor-mediated suppression of activator protein-1 activation and matrix metalloproteinase expression after spinal cord injury. J Neurosci. 2001; 21(1):92-7. PMC: 6762457. View